DCGO
DocGo Inc.Price & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted gross margin non-GAAP | 31.6% | Q1 2026 | — |
|
|
|||
| adjusted EBITDA non-GAAP | -$10.2M | Q1 2026 call | — |
|
|
|||
| home visits per day (mobile phlebotomy) | 600 | Q1 2026 call | — |
| lives assigned for care gap services since inception | 1.6M | since inception call | — |
| Medical Transportation adjusted gross margin non-GAAP | 31.9% | Q1 2026 call | — |
| Mobile Health adjusted gross margin non-GAAP | 31% | Q1 2026 call | — |
| PCP and longitudinal care panel | 1,000 | Q1 2026 call | — |
| SteadyMD total visits and lab orders | 1.1M | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DCGO
this stock
DocGo Inc.
|
$58.82M | -32.1% | -47.7% | — | 4.6% |
|
HCA
HCA Healthcare, Inc.
|
$93.86B | -9.2% | +7.1% | 14.6 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.09B | -13.0% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.99B | +5.1% | -2.3% | 10.9 | 4.7% |
|
DVA
Davita Inc.
|
$15.04B | +106.2% | +6.5% | 21.9 | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DCGO | +15.5% | +6.6% | -33.6% | +15.5% | -32.1% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +14.6% | +5.2% | -41.1% | +15.4% | -41.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.